Deepecho
Democratizing quality ultrasound
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- deepecho.io
- Last Round
- Pre-SeedFeb 2022
- Rounds
- 1
About
DeepEcho is a healthtech company building AI-powered fetal ultrasound analysis software to improve prenatal care and reduce infant and maternal mortality. Founded by AI scientists and physicians, DeepEcho uses deep learning algorithms to automate fetal measurements, assist with computer-aided diagnosis, and enable teleguidance for remote diagnosis — enabling screenings that are 3 to 5 times faster with greater than 95% accuracy. The platform is hardware-agnostic and mobile-compatible, designed for deployment in low-resource settings. DeepEcho received FDA 510(k) clearance in 2025 and has been backed by the Bill & Melinda Gates Foundation I3 Program and the European Bank for Reconstruction and Development.
Summary
Deepecho is a Healthcare company based in San Francisco, United States. Its most recent funding was a Pre-Seed round in Feb 2022. Investors include UM6P Ventures and Plug and Play.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2022
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
